-
How Did Analysts Get Gilead's Earnings Completely Wrong?
Wednesday, April 23, 2014 - 9:19am | 496Many, like CNBC’s Jim Cramer, would argue that the analyst community doesn’t get much of anything right. But it’s hard to argue that normally analysts are more than a few cents off when predicting a company’s quarterly EPS. So how did the analyst community get Tuesday’s Gilead (NASDAQ: GILD)...
-
Market Wrap For January 8: Fed Minutes Released
Wednesday, January 8, 2014 - 5:39pm | 2250Major indices finished Wednesday's trading session relatively flat as the Fed's minutes released had no impact on the markets. Minutes released from the Federal Reserve's latest meeting re-affirmed that many members on the committee wanted to proceed with caution in trimming the $85 billion...
-
Possible Hepatitis C Outbreak Could Lift This ETF
Monday, July 30, 2012 - 6:53am | 699David Kwiatkowski, who worked at 13 hospitals in eight states, was indicted last week on charges he allegedly infected 31 people at a New Hampshire hospital where he was previously employed with hepatitis C. As if that alarming discovery is not bad enough, Kwiatkowski, who is hepatitis C positive...